Successful treatment of advanced Freiberg's disease with a modified Weil osteotomy, 5-year follow up: A Pilot case series with a review of the literature.

INTRODUCTION: Treatment for Freiberg's disease is largely conservative. For severe disease and refractory cases, there are various surgical options. The purpose of this study was to report the 5-year clinical outcomes of a modified Weil osteotomy in the treatment of advanced Freiberg's disease. METHODS: Twelve patients (12 feet), with a mean age of 30.7 years (range 17-55), were treated with synovectomy and modified Weil osteotomy of the affected distal metatarsal head. There were 10 females and 2 males. Clinical outcomes were independently evaluated pre and postoperatively using the American Orthopaedic Foot and Ankle Society (AOFAS) scoring system and a subjective satisfaction score. Radiological union was evaluated postoperatively. Nine (75%) feet involved the 2nd metatarsal and 3 feet (25%) involved the 3rd metatarsal. According to the Smillie classification, 6 feet were Grade IV and 6 feet were grade V. RESULTS: No patients were lost to follow up and the mean follow-up time was 5.2 years (4-7). AOFAS scores improved from 48.1 + /- 7.4-88.9 + /- 10.1 postoperatively giving a mean improvement of 40.8 (p < 0.001). In total, 92% of patients were satisfied with their operation at latest follow-up, reporting excellent or good results. All patients had postoperative radiological union. One patient had a superficial postoperative infection that was successfully treated with oral antibiotics. CONCLUSION: Modified Weil osteotomy is an effective treatment for advanced Freiberg's disease with good outcomes and few complications.

Anomalous High-Temperature Magnetoresistance in a Dilute 2D Hole System.

We report an unusual magnetoresistance that strengthens with the temperature in a dilute two-dimensional (2D) hole system in GaAs/AlGaAs quantum wells with densities p=1.98-0.99×10^{10}/cm^{2} where r_{s}, the ratio between Coulomb energy and Fermi energy, is as large as 20-30. We show that, while the system exhibits a negative parabolic magnetoresistance at low temperatures (≲0.4 K) characteristic of an interacting Fermi liquid, a positive magnetoresistance emerges unexpectedly at higher temperatures, and grows with increasing temperature even in the regime T∼E_{F}, close to the Fermi energy. This unusual positive magnetoresistance at high temperatures can be attributed to the viscous transport of 2D hole fluid in the hydrodynamic regime where holes scatter frequently with each other. These findings give insight into the collective transport of strongly interacting carriers in the r_{s}≫1 regime and new routes toward magnetoresistance at high temperatures.

The Association of Pre-Transplant C-Peptide Level with the Development of Post-Transplant Diabetes: A Cohort Study.

Background: Post-transplant diabetes mellitus (PTDM) is an important complication after kidney transplantation that results in reduced patient and allograft survival. Although there are established risk factors for PTDM, whether pretransplant C-peptide levels associate with PTDM is unknown. Therefore, in this study, we aimed to examine the association of pretransplant C-peptide levels with PTDM. Methods: This was a cohort study of nondiabetic adult patients who underwent kidney transplant in Nova Scotia, Canada, between January 1, 2016, and March 31, 2021, with fasting C-peptide levels measured before transplant. Multivariable logistic regression was used to determine the association of pretransplant C-peptide (dichotomized around the median) with PTDM at 1 year post transplant. Given the known association between pretransplant obesity and PTDM, we repeated our primary analysis in a cohort restricted to a BMI of 20-35 kg/m2. Results: The median C-peptide value was 3251 (Q1 2480, Q3 4724); pretransplant C-peptide level was dichotomized at 3000 pmol/L. PTDM occurred in 25 (19%) individuals. Thirty percent of patients in the high and only 2% of patients in the low C-peptide groups developed PTDM (P<0.001). A C-peptide level ≥3000 pmol/L was strongly associated with PTDM in multivariable analysis (OR=18.9, 95% CI, 2.06 to 174.2). In a restricted cohort with a BMI of 20-35 kg/m2, an elevated pretransplant C-peptide remained independently associated with the risk of PTDM (OR=15.7, 95% CI, 1.64 to 150.3). C-peptide was the only factor independently associated with PTDM in this restricted BMI cohort. Conclusions: A pretransplant C-peptide level ≥3000 pmol/L was associated with a nearly 20-fold increased odds of PTDM at 1 year post kidney transplantation. Identifying patients with high pretransplant C-peptide levels may therefore help identify those at risk for PTDM who may benefit from focused preventative and therapeutic interventions and support.

Disparities in Access to Preemptive Repeat Kidney Transplant: Still Missing the Mark?

Background: The need for repeat transplant due to failing kidney allografts is increasing over time. The benefit of preemptive kidney retransplant (PKre-T) is controversial. Marginalized populations are less likely to undergo their first transplant preemptively; however, whether inequities exist for those undergoing PKre-T is unknown. Methods: We performed a cohort study of adult patients undergoing live and deceased kidney transplant in the United States from 2000 to 2018 identified using the Scientific Registry of Transplant Recipients, and we identified patients with first preemptive kidney transplant (PKT) and PKre-T. In the primary analysis, a multivariable logistic regression was used to identify independent predictors of PKre-T. In secondary analyses, multivariable Cox models were used to determine the association of PKre-T with death-censored and all-cause graft loss. Results: In total, 4910 (15.5%) patients underwent PKre-T, and 43,293 (19.1%) underwent first PKT. Inequities in access to PKre-T persisted (OR, 0.49; 95% CI, 0.44 to 0.55 for unemployed versus full time; OR, 1.61; 95% CI, 1.14 to 2.25 for graduate school versus not completing high school; OR, 0.61; 95% CI, 0.52 to 0.70 for Black versus White race); 7.1% of all transplanted Black patients received PKre-T versus 17.4% of White patients. Women were more likely to undergo PKre-T than men (OR, 1.42; 95% CI, 1.29 to 1.57). PKre-T was associated with superior graft survival relative to retransplant after a period of dialysis (HR, 0.73; 95% CI, 0.67 to 0.80 for all-cause graft failure; HR, 0.72; 95% CI, 0.65 to 0.81 for death-censored graft loss). Conclusions: Despite improved patient and graft survival, inequities in access to PKre-T persist. Patients with lower education, patients with reduced employment status, patients of Black race, and men are less likely to receive PKre-T.

Transport in helical Luttinger liquids in the fractional quantum Hall regime.

Domain walls in fractional quantum Hall ferromagnets are gapless helical one-dimensional channels formed at the boundaries of topologically distinct quantum Hall (QH) liquids. Naïvely, these helical domain walls (hDWs) constitute two counter-propagating chiral states with opposite spins. Coupled to an s-wave superconductor, helical channels are expected to lead to topological superconductivity with high order non-Abelian excitations1-3. Here we investigate transport properties of hDWs in the ν = 2/3 fractional QH regime. Experimentally we found that current carried by hDWs is substantially smaller than the prediction of the naïve model. Luttinger liquid theory of the system reveals redistribution of currents between quasiparticle charge, spin and neutral modes, and predicts the reduction of the hDW current. Inclusion of spin-non-conserving tunneling processes reconciles theory with experiment. The theory confirms emergence of spin modes required for the formation of fractional topological superconductivity.

Successful Use of Kidneys from a Deceased Donor with Active Herpes Zoster Infection.

BACKGROUND: The limited donor pool and increasing recipient wait list require a reevaluation of kidney organ suitability for transplantation. Use of higher infectious risk organs that were previously discarded may help improve access to transplantation and reduce patient mortality without placing patients at a higher risk of poor posttransplant outcomes. There is very little data available regarding the safe use of kidney organs from deceased donors with varicella zoster virus infection at the time of organ retrieval. Case Presentation. Here, we report a case of successful transplantation of both kidneys from a deceased donor with active herpes zoster infection at the time of organ retrieval. Recipients were treated preemptively with acyclovir. At 4 months posttransplant, both kidney recipients experienced no infectious complications and were off dialysis with functioning transplant grafts. CONCLUSIONS: The use of kidney organs from donors with active herpes zoster infection appears to be a safe option to expand the kidney donor pool.

Frailty Severity and Hospitalization After Dialysis Initiation.

BACKGROUND: Frailty is associated with hospitalization and mortality among dialysis patients. To now, few studies have considered the degree of frailty as a predictor of hospitalization. OBJECTIVE: We evaluated whether frailty severity was associated with hospitalization after dialysis initiation. DESIGN: Retrolective cohort study. SETTING: Nova Scotia, Canada. PATIENTS: Consecutive adult, chronic dialysis patients who initiated dialysis from January 1, 2009 to June 30, 2014, (last follow-up June, 2015). METHODS: Frailty Severity, as determined by the 7-point Clinical Frailty Scale (CFS, ranging from 1 = very fit to 7 = severely frail), was measured at dialysis initiation and treated as continuous and in categories (CFS scores of 1-3, 4/5, and 6/7). Hospitalization was characterized by cumulative time admitted to hospital (proportion of days admitted/time at risk) and by the joint risk of hospitalization and death. Time at risk included time in hospital after dialysis initiation and patients were followed until transplantation or death. RESULTS: Of 647 patients (mean age: 62 ± 15), 564 (87%) had CFS scores. The mean CFS score was 4 ("corresponding to "vulnerable") ± 2 ("well" to "moderately frail"). In an adjusted negative binomial regression model, moderate-severely frail patients (CFS 6/7) had a >2-fold increased risk of cumulative time admitted to hospital compared to the lowest CFS category (IRR = 2.18, 95% confidence interval [CI] = 1.31-3.63). In the joint model, moderate-severely frail patients had a 61% increase in the relative hazard for hospitalization (hazard ratio [HR] = 1.61, 95% CI = 1.29-2.02) and a 93% increase in the relative hazard for death compared to the lowest CFS category (HR = 1.93, 95% CI = 1.16-3.22). LIMITATIONS: Potential unknown confounders may have affected the association between frailty severity and hospitalization given observational study design. The CFS is subjective and different clinicians may grade frailty severity differently or misclassify patients on the basis of limited availability. CONCLUSIONS: Among incident dialysis patients, a higher frailty severity as defined by the CFS is associated with both an increased risk of cumulative time admitted to hospital and joint risk of hospitalization and death.

CONTEXTE: La fragilité est associée à davantage d'hospitalisations et de mortalité chez les patients qui suivent des traitements de dialyze. À l'heure actuelle, peu d'études se sont penchées sur le degré de fragilité comme facteur prédictif d'hospitalization. OBJECTIFS: Nous avons évalué l'existence d'un lien entre la gravité de la fragilité et le risque d'hospitalization après l'amorce d'un traitement de dialyze. TYPE D'ÉTUDE: Étude de cohorte rétrospective. CADRE: Nouvelle-Écosse, Canada. SUJETS: L'étude porte sur des patients adultes consécutifs sous dialyze chronique et ayant entrepris leur traitement entre le 1er janvier 2009 et le 30 juin 2014 (dernier suivi en juin 2015). MÉTHODOLOGIE: L'échelle CFS (Clinical Frailty Scale) en 7 points (1 = très bonne forme physique; 7= gravement fragile) a été employée pour déterminer le niveau de gravité de la fragilité. Cette dernière a été évaluée à l'amorce de la dialyze et traitée en tant que mesure continue et selon trois niveaux d'atteinte (scores CFS de 1-3, de 4-5 et de 6-7). L'hospitalization a été caractérisée par la durée cumulative des hospitalisations (proportion de jours d'hospitalization/l'intervalle de risque) et par un risque conjoint d'hospitalization et de décès. L'intervalle de risque comprend le temps passé à l'hôpital depuis le début du traitement. Les patients ont été suivis jusqu'à la transplantation ou jusqu'au décès. RÉSULTATS: Parmi les 647 patients admissibles (âge moyen: 62 ans ± 15), 564 patients (87 %) disposaient d'un score CFS. Le score CFS moyen était de 4 (correspondant à « apparence de vulnérabilité ¼) ± 2 (« bonne forme physique ¼ à « modérément fragile ¼). Dans un modèle corrigé de régression binomiale négative, les patients jugés modérément à gravement fragiles (CFS 6/7) présentaient un risque cumulatif plus de 2 fois plus élevé d'être hospitalisés comparativement aux patients du groupe avec le score CFS le plus faible (RTI: 2,18; IC 95 %: 1,31 à 3,63). Dans le modèle conjoint, les patients jugés modérément à gravement fragiles ont présenté une augmentation de 61 % du risque relatif d'hospitalization (RR:1,61; IC 95 %: 1,29 à 2,02) et une augmentation de 93 % du risque relatif de décès comparativement aux patients avec le score CFS le plus faible (RR: 1,93; IC 95 %: 1,16 à 3,22). LIMITES: La méthodologie de l'étude (observationnelle) laisse supposer que de possibles facteurs confusionnels inconnus pourraient avoir eu une incidence sur le lien entre les hospitalisations et la gravité de la fragilité. Le score CFS est une mesure subjective. Il est possible que les cliniciens évaluent différemment la gravité de la fragilité ou classent les patients de façon erronée en raison d'une disponibilité limitée. CONCLUSION: Chez les patients dialysés, une plus grande fragilité, telle que définie par le score CFS, a été associée à la fois à un risque accru d'être hospitalisé sur une plus longue durée cumulative et à un risque conjoint d'hospitalization et de décès.

Quasicondensation of Bilayer Excitons in a Periodic Potential.

We study two-dimensional excitons confined in a lattice potential, for high fillings of the lattice sites. We show that a quasicondensate is possibly formed for small values of the lattice depth, but for larger ones the critical phase-space density for quasicondensation rapidly exceeds our experimental reach, due to an increase of the exciton effective mass. On the other hand, in the regime of a deep lattice potential where excitons are strongly localized at the lattice sites, we show that an array of phase-independent quasicondensates, different from a Mott insulator, is realized.

Prevalence of Frailty in Patients Referred to the Kidney Transplant Waitlist.

Background: Comparisons between frailty assessment tools for waitlist candidates are a recognized priority area for kidney transplantation. We compared the prevalence of frailty using three established tools in a cohort of waitlist candidates. Methods: Waitlist candidates were prospectively enrolled from 2016 to 2020 across five centers. Frailty was measured using the Frailty Phenotype (FP), a 37-variable frailty index (FI), and the Clinical Frailty Scale (CFS). The FI and CFS were dichotomized using established cutoffs. Agreement was compared using κ coefficients. Area under the receiver operating characteristic (ROC) curves were generated to compare the FI and CFS (treated as continuous measures) with the FP. Unadjusted associations between each frailty measure and time to death or waitlist withdrawal were determined using an unadjusted Cox proportional hazards model. Results: Of 542 enrolled patients, 64% were male, 80% were White, and the mean age was 54±14 years. The prevalence of frailty by the FP was 16%. The mean FI score was 0.23±0.14, and the prevalence of frailty was 38% (score of ≥0.25). The median CFS score was three (IQR, 2-3), and the prevalence was 15% (score of ≥4). The κ values comparing the FP with the FI (0.44) and CFS (0.27) showed fair to moderate agreement. The area under the ROC curves for the FP and FI/CFS were 0.86 (good) and 0.69 (poor), respectively. Frailty by the CFS (HR, 2.10; 95% CI, 1.04 to 4.24) and FI (HR, 1.79; 95% CI, 1.00 to 3.21) was associated with death or permanent withdrawal. The association between frailty by the FP and death/withdrawal was not statistically significant (HR, 1.78; 95% CI, 0.79 to 3.71). Conclusion: Frailty prevalence varies by the measurement tool used, and agreement between these measurements is fair to moderate. This has implications for determining the optimal frailty screening tool for use in those being evaluated for kidney transplant.

COVID-19 Status, Symptom Burden, and Characteristics of Dialysis Patients Residing in Areas of Community Transmission: Research Letter.

BACKGROUND: Routine testing of hemodialysis patients for COVID-19 (outside of those identified as "at risk" based on regional practice) is not universally recommended. However, there is variability in the clinical presentation of COVID-19; patients may experience symptoms that do not meet regional criteria for testing and some patients with active infection may be asymptomatic. To avoid missing individuals who are infected, consideration could be made for regular screening, particularly among those residing in areas with evidence of community spread. OBJECTIVE: To describe the clinical characteristics, symptom burden, and COVID-19 status in a cross-section of hemodialysis patients residing in areas with evidence of community spread. DESIGN: Cross-sectional study. SETTING: Three hemodialysis units in a large tertiary care facility in Nova Scotia, Canada. PATIENTS: In-center hemodialysis patients who resided in areas with evidence of community transmission at the time of the study. METHODS: All dialysis patients (irrespective of whether or not they resided in areas with community spread) completed a standard "at-risk" questionnaire for COVID-19 based on (1) 2 or more of new or worsening cough, fever greater than 38°C, sore throat, headache, runny nose/new or acute respiratory illness consistent with infection or (2) any one of close contact with a known/suspected case, travel outside of the province or residence in a facility with an outbreak prior to entry into the dialysis unit at each treatment. Patients residing in areas with evidence of community spread were swabbed for SARS-CoV-2 over a 1-week period (May 1-7, 2020) using a combined oropharyngeal/nares swab irrespective of whether or not they were identified as "at-risk." MEASUREMENTS: Baseline characteristics of patients were acquired using electronic records. In addition to the "at-risk" questionnaire, patients answered "yes" or "no" to any of the following symptoms at the time of the swab (sneeze, fatigue, myalgia, nausea/vomiting, diarrhea, malaise, abdominal pain, loss of taste, and loss of smell). RESULTS: Of the 334 patients receiving dialysis at the time of the study, 133 resided in areas with evidence of community transmission and 104 consented for the study. No patients met our regional criteria for being "at-risk" and no patients reported cough, sore throat or fever at the time of swab. Many other symptoms were noted, including sneezing (24%), fatigue (16%), myalgias (11%), nausea/vomiting (11%), loss of taste (4%), and loss of smell (4%). Overall, 100% of swabs performed for this study were negative for SARS-CoV-2. LIMITATIONS: Single-center study, and the daily new case rate was exceedingly low (4-14) at the time of the study, emphasizing that the findings are not generalizable to areas of higher prevalence of SARS-CoV-2. CONCLUSIONS: In this study of hemodialysis patients residing in areas with community spread who otherwise did not meet symptom criteria for being "at-risk," we did not identify any individual who tested positive for SARS-CoV-2. Future studies are needed to examine the utility of routine testing for COVID-19 (outside of those who are "at-risk") in areas of higher disease prevalence. TRIAL REGISTRATION: Not applicable as this is not a clinical trial.

Frailty and the Kidney Transplant Wait List: Protocol for a Multicenter Prospective Study.

BACKGROUND: Understanding how frailty affects patients listed for transplantation has been identified as a priority research need. Frailty may be associated with a high risk of death or wait-list withdrawal, but this has not been evaluated in a large multicenter cohort of Canadian wait-listed patients. OBJECTIVE: The primary objective is to evaluate whether frailty is associated with death or permanent withdrawal from the transplant wait list. Secondary objectives include assessing whether frailty is associated with hospitalization, quality of life, and the probability of being accepted to the wait list. DESIGN: Prospective cohort study. SETTING: Seven sites with established renal transplant programs that evaluate patients for the kidney transplant wait list. PATIENTS: Individuals who are being considered for the kidney transplant wait list. MEASUREMENTS: We will assess frailty using the Fried Phenotype, a frailty index, the Short Physical Performance Battery, and the Clinical Frailty Scale at the time of listing for transplantation. We will also assess frailty at the time of referral to the wait list and annually after listing in a subgroup of patients. METHODS: The primary outcome of the composite of time to death or permanent wait-list withdrawal will be compared between patients who are frail and those who are not frail and will account for the competing risks of deceased and live donor transplantation. Secondary outcomes will include number of hospitalizations and length of stay, and in a subset, changes in frailty severity over time, change in quality of life, and the probability of being listed. Recruitment of 1165 patients will provide >80% power to identify a relative hazard of ≥1.7 comparing patients who are frail to those who are not frail for the primary outcome (2-sided α = .05), whereas a more conservative recruitment target of 624 patients will provide >80% power to identify a relative hazard of ≥2.0. RESULTS: Through December 2019, 665 assessments of frailty (inclusive of those for the primary outcome and all secondary outcomes including repeated measures) have been completed. LIMITATIONS: There may be variation across sites in the processes of referral and listing for transplantation that will require consideration in the analysis and results. CONCLUSIONS: This study will provide a detailed understanding of the association between frailty and outcomes for wait-listed patients. Understanding this association is necessary before routinely measuring frailty as part of the wait-list eligibility assessment and prior to ascertaining the need for interventions that may modify frailty. TRIAL REGISTRATION: Not applicable as this is a protocol for a prospective observational study.

CONTEXTE: La compréhension de l'incidence de la fragilité sur les patients en attente d'une greffe rénale a été désignée comme un besoin prioritaire de recherche. La fragilité pourrait être associée à un risque élevé de mortalité ou de se voir retiré de la liste d'attente pour une transplantation, mais elle n'a jamais été évaluée dans une vaste cohorte multicentrique de patients canadiens en attente d'une greffe. OBJECTIFS: Le principal objectif consiste à déterminer si la fragilité d'un patient l'expose à un plus grand risque de décès ou de retrait permanent de la liste d'attente pour une greffe. Nous souhaitons également vérifier s'il existe un lien entre la fragilité et le nombre d'hospitalisations, la qualité de vie et la probabilité d'être accepté sur la liste d'attente. TYPE D'ÉTUDE: Étude de cohorte prospective. CADRE: Sept sites disposant d'un programme de transplantation rénale évaluant les patients en vue de leur inscription sur la liste d'attente pour une greffe. SUJETS: Des candidats à la liste d'attente pour une transplantation rénale. MESURES: La fragilité sera évaluée à l'aide du Phénotype de Fried (un indice de la fragilité), du test SPPB (Short Physical Performance Battery) et de l'échelle Clinical Frailty Scale au moment de l'inscription sur la liste d'attente pour une transplantation. Nous mesurerons la fragilité des patients de leur orientation vers le programme jusqu'à leur inscription sur la liste, puis sur une base annuelle après leur inclusion dans un sous-groupe de patients. MÉTHODOLOGIE: Le résultat principal, soit un composite du délai avant le décès ou le retrait permanent de la liste, sera comparé entre les patients fragiles et non fragiles, et tiendra compte des risques concurrents découlant de la transplantation selon que l'organe provient d'un donneur vivant ou décédé. Les résultats secondaires comprendront le nombre d'hospitalisations et leur durée, les variations de la fragilité et de la qualité de vie au fil du temps (pour un sous-groupe de patients), de même que les probabilités d'être inscrit sur la liste d'attente. Le recrutement de 1 165 patients nous permettrait d'obtenir un risque relatif d'au moins 1,7 dans plus de 80 % des cas lors de la comparaison des patients fragiles à ceux qui ne le sont pas pour le résultat principal (double erreur alpha = 0,05), alors que ce risque relatif serait de 2,0 avec un objectif de recrutement plus conservateur de 624 patients. RÉSULTATS: Un total de 665 évaluations de la fragilité (tant pour le résultat primaire que pour les résultats secondaires, y compris les mesures répétitives) a été complété en décembre 2019. LIMITES: Les résultats et leur analyse devront tenir compte des possibles variations entre les différents sites en ce qui concerne les processus d'aiguillage et d'inscription sur les listes d'attente pour une greffe. CONCLUSION: Cette étude fournira une compréhension détaillée de l'association entre la fragilité et les résultats cliniques pour les patients en attente d'une greffe. La compréhension de cette association est nécessaire avant d'inclure systématiquement la mesure de la fragilité au processus d'évaluation de l'admissibilité à la liste d'attente et avant d'établir le besoin de procéder à des interventions susceptibles de modifier la fragilité du patient.

Observation of quantum depletion in a non-equilibrium exciton-polariton condensate.

Superfluidity, first discovered in liquid 4He, is closely related to Bose-Einstein condensation (BEC) phenomenon. However, even at zero temperature, a fraction of the quantum liquid is excited out of the condensate into higher momentum states via interaction-induced fluctuations-the phenomenon of quantum depletion. Quantum depletion of atomic BECs in thermal equilibrium is well understood theoretically but is difficult to measure. This measurement is even more challenging in driven-dissipative exciton-polariton condensates, since their non-equilibrium nature is predicted to suppress quantum depletion. Here, we observe quantum depletion of a high-density exciton-polariton condensate by detecting the spectral branch of elementary excitations populated by this process. Analysis of this excitation branch shows that quantum depletion of exciton-polariton condensates can closely follow or strongly deviate from the equilibrium Bogoliubov theory, depending on the exciton fraction in an exciton polariton. Our results reveal beyond mean-field effects of exciton-polariton interactions and call for a deeper understanding of the relationship between equilibrium and non-equilibrium BECs.

Directional Goldstone waves in polariton condensates close to equilibrium.

Quantum fluids of light are realized in semiconductor microcavities using exciton-polaritons, solid-state quasi-particles with a light mass and sizeable interactions. Here, we use the microscopic analogue of oceanographic techniques to measure the excitation spectrum of a thermalised polariton condensate. Increasing the fluid density, we demonstrate the transition from a free-particle parabolic dispersion to a linear, sound-like Goldstone mode characteristic of superfluids at equilibrium. Notably, we reveal the effect of an asymmetric pumping by showing that collective excitations are created with a definite direction with respect to the condensate. Furthermore, we measure the critical sound speed for polariton superfluids close to equilibrium.

Self-Trapping of Exciton-Polariton Condensates in GaAs Microcavities.

The self-trapping of exciton-polariton condensates is demonstrated and explained by the formation of a new polaronlike state. Above the polariton lasing threshold, local variation of the lattice temperature provides the mechanism for an attractive interaction between polaritons. Because of this attraction, the condensate collapses into a small bright spot. Its position and momentum variances approach the Heisenberg quantum limit. The self-trapping does not require either a resonant driving force or a presence of defects. The trapped state is stabilized by the phonon-assisted stimulated scattering of excitons into the polariton condensate. While the formation mechanism of the observed self-trapped state is similar to the Landau-Pekar polaron model, this state is populated by several thousands of quasiparticles, in a striking contrast to the conventional single-particle polaron state.

Spatial Mapping of Local Density Variations in Two-dimensional Electron Systems Using Scanning Photoluminescence.

We have developed a scanning photoluminescence technique that can directly map out the local two-dimensional electron density with a relative accuracy of ∼2.2 × 108 cm-2. The validity of this approach is confirmed by the observation of the expected density gradient in a high-quality GaAs quantum well sample that was not rotated during the molecular beam epitaxy of its spacer layer. In addition to this global variation in electron density, we observe local density fluctuations across the sample. These random density fluctuations are also seen in samples that were continuously rotated during growth, and we attribute them to residual space charges at the substrate-epitaxy interface. This is corroborated by the fact that the average magnitude of density fluctuations is increased to ∼9 × 109 cm-2 from ∼1.2 × 109 cm-2 when the buffer layer between the substrate and the quantum well is decreased by a factor of 7. Our data provide direct evidence for local density inhomogeneities even in very high-quality two-dimensional carrier systems.

Optical frequency combs from high-order sideband generation.

We report on the generation of frequency combs from the recently-discovered phenomenon of high-order sideband generation (HSG). A near-band gap continuous-wave (cw) laser with frequency fNIR was transmitted through an epitaxial layer containing GaAs/AlGaAs quantum wells that were driven by quasi-cw in-plane electric fields FTHz between 4 and 50 kV/cm oscillating at frequencies fTHz between 240 and 640 GHz. Frequency combs with teeth at fsideband = fNIR + nfTHz (n even) were produced, with maximum reported n > 120, corresponding to a maximum comb span > 80 THz. Comb spectra with the identical product fTHz × FTHz were found to have similar spans and shapes in most cases, as expected from the picture of HSG as a scattering-limited electron-hole recollision phenomenon. The HSG combs were used to measure the frequency and linewidth of our THz source as a demonstration of potential applications.

Strongly interacting dipolar-polaritons.

Exciton-polaritons are mutually interacting quantum hybridizations of confined photons and electronic excitations. Here, we demonstrate a system of optically guided, electrically polarized exciton-polaritons ("dipolaritons") that displays up to 200-fold enhancement of the polariton-polariton interaction strength compared to unpolarized polaritons. The magnitude of the dipolar interaction enhancement can be turned on and off and can be easily tuned over a very wide range by varying the applied polarizing electric field. The large interaction strengths and the very long propagation distances of these fully guided dipolaritons open up new opportunities for realizing complex quantum circuitry and quantum simulators, as well as topological states based on exciton-polaritons, for which the interactions between polaritons need to be large and spatially or temporally controlled. The results also raise fundamental questions on the origin of these large enhancements.